首页> 外国专利> Quantification of human nervous disease with amyloid deposition consists of detection via antibody based on normal and mutant transtirretin

Quantification of human nervous disease with amyloid deposition consists of detection via antibody based on normal and mutant transtirretin

机译:淀粉样蛋白沉积对人类神经疾病的定量分析包括通过基于正常和突变型转酪蛋白的抗体进行检测

摘要

Quantification of human nervous disease with amyloid deposition comprising detection of TTR (transtirretin) by incubation of tissues, deparaffinated dehydrated with electro-immunization in agarose gel containing the antibody based on normal and mutant TTR, is new. An independent claim is also included for production of the disease specific antibody by immunization of rats with TTR Phe 78 and fusion of the rat spleen with myeloma cells for selection of hybridomas. The and incubated with the antibody, employ.
机译:淀粉样蛋白沉积对人类神经疾病的量化包括通过组织孵育检测TTR(反式维甲酸),在含有基于正常TTR和突变TTR的抗体的琼脂糖凝胶中进行电免疫脱水去石蜡脱水。还包括一个独立的权利要求,用于通过用TTR Phe 78免疫大鼠并将大鼠脾脏与骨髓瘤细胞融合以产生疾病特异性抗体,以选择杂交瘤。并与抗体一起孵育。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号